Evidence map›Paper›PMID 31813079›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2020

Determination of pentraxin 3 levels in cerebrospinal fluid during central nervous system infections.

Marta Zatta, Stefano Di Bella, Barbara Bottazzi, Francesca Rossi, Pierlanfranco D'Agaro, Ludovica Segat, Massimiliano Fabbiani, Alberto Mantovani, Roberto Luzzati

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Marta ZattaDepartment of Infectious Diseases, University Hospital of Trieste, Trieste, Italy. martazatta@gmail.com.ORCID http://orcid.org/0000-0002-8048-8573
Stefano Di BellaDepartment of Infectious Diseases, University Hospital of Trieste, Trieste, Italy.
Barbara BottazziIRCCS Humanitas Clinical and Research Center and Humanitas University, Milan, Italy.
Francesca RossiDepartment of Laboratory Medicine, University Hospital of Trieste, Trieste, Italy.
Pierlanfranco D'AgaroDepartment Reproductive, Developmental and Public Health Sciences, UCO Hygiene and Preventive Medicine, University of Trieste, Trieste, Italy.
Ludovica SegatDepartment Reproductive, Developmental and Public Health Sciences, UCO Hygiene and Preventive Medicine, University of Trieste, Trieste, Italy.
Massimiliano FabbianiDepartment of Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Alberto MantovaniIRCCS Humanitas Clinical and Research Center and Humanitas University, Milan, Italy.
Roberto LuzzatiDepartment of Infectious Diseases, University Hospital of Trieste, Trieste, Italy.
University of Trieste · ITHumanitas University · ITPoliclinico San Matteo Fondazione · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pentraxin 3 (PTX3) is an acute phase protein; its plasmatic levels significantly rise during severe infections. Data on PTX3 levels in cerebrospinal fluid (CSF) of patients with central nervous system (CNS) infections are lacking. We aimed (a) to assess the diagnostic potential of measuring CSF PTX3 levels in patients with CNS infections and (b) to establish CSF PTX3 cutoffs to distinguish between bacterial and aseptic meningoencephalitis (ROC curve). PTX3 levels were measured in CSF from 19 patients admitted to Trieste Hospital, Italy, with CNS infection. A diagnosis of bacterial infection and aseptic meningoencephalitis was made in 7 (37%) and 12 (63%) patients, respectively. Subjects with bacterial infections showed significantly higher PTX3 levels (13.5 vs 1.27 ng/mL in aseptic meningoencephalitis, p = 0.010). We identified two different CSF PTX3 levels cutoffs. (1) The best cutoff to maximise Youden's J was 9.6 ng/mL with a sensitivity, specificity, positive predictive value and negative predictive value (NPV) of 71.4%, 91.4%, 83.3%, 84.6%, respectively. (2) The cutoff with higher NPV (100%) was 3.6 ng/mL; a diagnosis of bacterial infections was obtained in 0% patients with CSF PTX3 levels < 3.6 ng/mL vs 58% of those with CSF PTX3 levels ≥ 3.6 ng/mL (p = 0.017). CSF PTX3 levels are higher in bacterial meningitis than aseptic meningoencephalitis. A cutoff of 3.6 ng/mL of CSF PTX3 has a high NPV and can be used to exclude bacterial CNS infections.

Indexed as

AdultAgedAged, 80 and overBacteriaBiomarkersCentral Nervous System InfectionsC-Reactive ProteinDiagnosis, DifferentialFemaleHumansItalyMaleMeningitis, AsepticMeningitis, BacterialMeningoencephalitisMiddle AgedBiomarkersC-Reactive ProteinPentraxinsSerum Amyloid P-ComponentCentral nervous system infectionsEtiologyMeningitisPentraxin3

Identifiers

PMID31813079
OpenAlexW2993700808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.